Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged From 1 to 12 Years With ARI (Acute Respiratory Infection)

NCT03840135 is registered in ClinicalTrials.gov with NPO Petrovax as lead sponsor.

NCT NCT03840135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03840135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged From 1 to 12 Years With ARI (Acute Respiratory Infection)
Lead sponsor
NPO Petrovax
Phase
Phase 3
Overall status
Completed
Start date
November 7, 2018
Completion date
December 10, 2019
Enrollment
172 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory infection